Revolution Medicines
RVMD----
Revolution Medicines (RVMD)
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Revolution Medicines Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$207.009.39%
Forecast & RatingStrong buy
22analysts
- Strong buy77.27%
- Buy18.18%
- Hold4.55%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 22 at 04:35 PM
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price Target
- PUBT · Jul 22 at 03:11 PM
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancer
- prnewswire · Jul 21 at 03:28 PM
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
- Global Report · Jul 21 at 04:13 AM
The Unbundling of Sectors: Decoding the Long Tail of the 2026 Market
- benzinga_article · Jul 17 at 12:35 PM
4 Health Care Stocks Whale Activity In Today’s Session
- prnewswire · Jul 14 at 08:45 PM
21:44 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
